Ventricular Pacing Site Selection (V-PASS)
Atrioventricular Block
About this trial
This is an interventional prevention trial for Atrioventricular Block focused on measuring Cardiac Pacing, artificial, Atrial Fibrillation, Heart failure, Pacemaker leads, Lead position, Higher degree AV-Block
Eligibility Criteria
Inclusion Criteria: Patients with an expected ventricular stimulation rate of >60% in planned pacing therapy. This will be the following pacing indications Symptomatic first-degree AV block, PQ time >250ms Second-degree Av block with permanent 2:1 conduction Permanent third-degree AV block Paroxysmal first-degree to third-degree Av block, with an anticipated rate of ventricular stimulation >60% Symptomatic bradyarrhythmia absoluta with permanent atrial fibrillation, with an anticipated rate of ventricular stimulation >60% Exclusion Criteria: heart failure acc. NYHA III or IV Intra-atrial conduction delay (P-wave > 150ms) Myocardial infarction less then 6 months before pacemaker implant hypertrophic obstructive cardiomyopathy Cardiogenic shock pregnancy Lactation period Patients under 18 years of age
Sites / Locations
- Herzzentrum Bad Krozingen, ElektrophysiologieRecruiting
- Universitätsklinikum Heidelberg, Innere Medizin III
- Oberschwaben Klinik GmbH, Krankenhaus Wangen, Innere Med.